// App-Quantinova.ai

Tu1138 : Efficacy of Vedolizumab in Crohn's Disease by Prior Treatment Failure in Gemini II, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Study

Researchers

Presenter

  • Brian G. Feagan

Principal Investigators

  • Donald G. MacIntosh

  • Jing Xu

  • Catherine Milch

  • Irving Fox

  • Michael D. Smyth

Medical Centers

  • The University of Chicago Medical Center, Chicago, IL

  • Robarts Research Institute, University of Western Ontario, London, Ontario, Canada

  • Dalhousie University, Halifax, Nova Scotia, Canada.

Locations

  • United States

  • Canada

Companies

  • Millennium Pharmaceu

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • C reactive protein

  • Faecal calprotectin

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved